A maternal screening program for congenital Toxoplasmosis in Quindio, Colombia and application of mathematical models to estimate incidences using age-stratified data

American Journal of Tropical Medicine and Hygiene

Volumn 57, Issue 2, 1997, Pages 180-186

  Gomez Marin, Jorge Enrique ^a,b   Montoya De Londono, Maria Teresa ^a   Castano Osorio, John Carlos ^a  

^a UNIVERSIDAD DEL QUINDÍO   (Colombia)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FANSIDAR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PYRIMETHAMINE; SPIRAMYCIN; SULFADOXINE;

ADULT; AGE; ANTIGEN ANTIBODY REACTION; ARTICLE; COLOMBIA; CONGENITAL TOXOPLASMOSIS; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; INFANT; MAJOR CLINICAL STUDY; MATERNAL DISEASE; MATHEMATICAL MODEL; NEWBORN; PRENATAL SCREENING; QUESTIONNAIRE; RISK FACTOR; SACCHAROMYCES CEREVISIAE; SEROPREVALENCE; TOXOPLASMA GONDII;

SACCHAROMYCES CEREVISIAE; TOXOPLASMA GONDII;

EID: 0030743221     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1997.57.180     Document Type: Article

References (31)

1. Wong SY, Remington JS, 1994. Toxoplasmosis in pregnancy. Clin Infect Dis 18: 853-862.
2. Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H, 1986. Results of 20 year follow up of congenital toxoplasmosis. Lancet i: 254-256.
3. Wilson CB, Remington JS, Stagno S, Reynolds DW, 1980. Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 66: 767-774.
4. Juliao RO, Corredor CA, Moreno GS, 1983. Toxoplasmosis en Colombia. Estudio Nacional de Salud. Bogota: Imprenta Instituto Nacional de Salud, 1-67.
5. Papoz L, Simondon F, Saurin W, Sarmini H, 1986. A simple model relevant to toxoplasmosis applied to epidemiologic results in France. Am J Epidemiol 123: 154-161.
6. Zuber PLF, Jacquier P, Holhifeld P, Walker M, 1995. Toxoplasma infection among pregnant women in Switzerland: a cross sectional evaluation of regional and age specific lifetime average annual incidence. Am J Epidemiol 141: 659-666.
7. Gobernacion del Quindio, 1989. Quindio Estadistico. Armenia: Asculquin Editores, 45-50.
8. Juliao O, Moreno GS, 1981. Manual de Tecnicas de Laboratorio. Estudio Nacional de Salud. Bogota: Imprenta Ministerio de Salud, 112-118.
9. Gomez JE, Londono MT, Castano JC, Perez JC, Rios MP, 1993. Epidemiologia de la infeccion por Toxoplasma gondii en gestantes de Armenia, Quindio, Colombia. Colombia Med 24: 14-18.
10. Lappalainen M, Koskela P, Koskiniemi M, Ammala P, Hiilesmaa V, Terano K, Raivio KO, Remington JS, 1993. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis 167: 691-697.
11. Ades AE, 1992. Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data. Epidemiol Infect 108: 367-375.
12. Francis JM, Joynson DHM, 1993. Duration of specific immunoglobulin A antibody following acute toxoplasmosis as determined by enzyme immunoassay and immunosorbent agglutination assay. Eur J Clin Microbiol Infect Dis 12: 556-559.
13. Gomez JE, 1992. Tratamiento de la toxoplasmosis adquirida durante el embarazo y en el recien nacido con infeccion congenita: presentacion de las normas del programa de control y vigilancia epidemiologica para la toxoplasmosis congenita en el Departamento del quindio. SE Investiga 4: 27-37.
14. Schwartz D, 1969. Methodes Statistiques a l'Usage des Medecins et Biologistes. Paris: Ed. Flammarion, 1-306.
15. Remington JS, Desmonts G, 1990. Toxoplasmosis. Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. Third edition. Philadelphia: W. B. Saunders, 89-195.
16. Lappalainen M, Koskela P, Hedman K, Teramo K, Ammala P, Hiilesmaa V, Koskiniemi M, 1992. Incidence of primary Toxoplasma infection during pregnancy in southern Finland: a prospective cohort study. Scand J Infect Dis 24: 97-104.
17. Sever JL, Ellenberg JH, Ley AC, Madden DL, Fucillo DA, Tzan NR, Edoms DM, 1988. Toxoplasmosis: maternal and pediatric findings in 23,000 pregnancies. Pediatrics 82: 181-192.
18. Editorial, 1990. Antenatal screening for toxoplasmosis in the U.K. Lancet 336: 346-348.
19. Guzman N, Basurto S, Orostegui M, Ortega E, 1989. Instituto para ninos ciegos y sordos de Cali: algunos aspectos epidemiologicos. Acta Pediatr Col 1: 20-24.
20. Romero J, 1990. El Sindrome TORCHS en perinatologia. Pediatria 25: 51-61.
21. Jeannel D, Costagliola D, Niel G, Hubert B, Danis M, 1990. What is known about the prevention of congenital toxoplasmosis. Lancet 336: 359-361.
22. Frenkel JK, 1981. Congenital toxoplasmosis: prevention or palliation? Am J Obstet Gynecol 141: 359-361. 20: 727-728.
23. Frenkel JK, 1981. Congenital toxoplasmosis: prevention or palliation? Am J Obstet Gynecol 141: 359-361. 20: 727-728.
24. McCabe R, Remington JS, 1988. Toxoplasmosis: the time has come. N Engl J Med 318: 313-315.
25. Hartup C, Johnson JD, Holliman RE, 1992. Medical audit of the investigation of toxoplasmosis associated with pregnancy. Lancet 340: 118-119.
26. Guerina NG, Hsu HW, Meissner C, Maguire JH, Lynfield R, Stechenberg B, Abrams I, Pasternack MS, Hoff R, Eaton RB, Grady G, and the New England Regional Toxoplasma Working Group, 1994. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 330: 1858-1863.
27. Foulon W, Naessens A, Derde MP, 1994. Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol 11: 57-62.
28. Conyn-van Spaendock MAE, van Knapen F, 1992. Choices in preventive strategies: experiences with the prevention of congenital toxoplasmosis in the Netherlands. Scand J Infect Dis 84 (suppl): 51-58.
29. Frenkel JK, Ruiz A, 1980. Human toxoplasmosis and cat contact in Costa Rica. Am J Trop Med Hyg 29: 1167-1180.
30. Frenkel JK, Ruiz A, 1981. Endemicity of toxoplasmosis in Costa Rica. Transmission between cats, soil, intermediate hosts, and humans. Am J Epidemiol 113: 254-269.
31. Lapalainen M, Sintonen H, Koskiniemi M, Hedman K, Hiilesmaa V, Ammala P, Teramo K, Koskela P, 1995. Cost-benefit analysis of screening for toxoplasmosis during pregnancy. Scand J Infect Dis 27: 265-272.